article thumbnail

Humira generic availability, cost, and dosage

The Checkup by Singlecare

The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. The pharmaceutical company that makes Hyrimoz is called Cordavis Limited. Cyltezo is citrate-free.

Dosage 97
article thumbnail

Eliquis generic availability, cost, and dosage

The Checkup by Singlecare

As of 2020, it was the 48th most popularly prescribed medication in the United States, with over 3 million Americans filling almost 14 million Eliquis prescriptions. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week.

Dosage 82
article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. million in 2021 and $607 million in 2020, as per its financial filings. The company’s market cap is $455.6 per 1,000mg dosage compared to Amarin’s $4.14

article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 2020-02-24.

FDA 73
article thumbnail

The NIH on accelerating research using diverse biomedical datasets

pharmaphorum

“For example, in early 2020, we enrolled somewhere between 3,000 to 3,500 participants each week. In March 2020, when the pandemic hit, we had to pause in-person recruitment. Understanding these differences across diverse populations can help doctors and HCPs determine what medication and dosage best fit a patient.

FDA 90
article thumbnail

Are microtaggants the key to making medicines smarter?

pharmaphorum

Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients. Instant verification at the dosage level reduces the risk of counterfeiting and product diversion while facilitating quality control and returns monitoring. About the author . appeared first on.